Talk:Kidney tumours: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
→RCC and BRCA2 mutations: new section |
||
| Line 9: | Line 9: | ||
The patient is eligible for genetic testing via Cancer Care Ontario's Hereditary Cancer Testing program, as they are less than age 45 years at the time of the diagnosis. | The patient is eligible for genetic testing via Cancer Care Ontario's Hereditary Cancer Testing program, as they are less than age 45 years at the time of the diagnosis. | ||
https://www.cancercareontario.ca/sites/ccocancercare/files/guidelines/full/HCTEligibilityCriteriaV3_0.pdf | https://www.cancercareontario.ca/sites/ccocancercare/files/guidelines/full/HCTEligibilityCriteriaV3_0.pdf | ||
== RCC and BRCA2 mutations == | |||
https://pubmed.ncbi.nlm.nih.gov/39673614/ CK7+ CK20+ CAIX+ | |||